Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer-Reference-Cited by-同舟云学术

Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer

Published:1988-12 Issue:6 Volume:42 Page:842-845
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Gusterson B.A.,Machin L.G.,Gullick W.J.,Gibbs N.M.,Powles T.J.,Price P.,McKinna A.,Harrison S.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference16 articles.

1. Theneu oncogene encodes an epidermal growth factor receptor-related protein;Bargmann;Nature (Lond.),1986a

2. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185;Bargmann;Cell,1986b

3. Correlation of cerbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading;Berger;Cancer Res.,1988

4. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene;Coussens;Science,1985

5. erbB-2 is a potent oncogene when overex-pressed in NIH/3T3 cells;DiFiore;Science,1987

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast;Handbook of Practical Immunohistochemistry;2022

2. Pathology of Ductal Carcinoma In Situ: Features and Diagnostic Challenges;Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer;2015

3. Breast;Handbook of Practical Immunohistochemistry;2015

4. Invasive cancers are not necessarily from preformed in situ tumours — an alternative way of carcinogenesis from misplaced stem cells;Journal of Cellular and Molecular Medicine;2013-06-07

5. Monoclonal Antibodies for Cancer Therapy and Prevention;Cancer Immunotherapy;2013